top headlines
Lonza has acquired the rights to Nona Biosciences’ transferrin receptor [...]
Telix Pharmaceuticals has received FDA agreement on the protocol and [...]
Movers & Shakers
sponsored content
With 89% of AI pilots failing to scale, biopharmas can [...]
Interview with Carol Grassi Mircich, chief commercial marketing and innovation [...]
As Rare Disease Day 2026 highlights the challenges faced by [...]
Other news
SERB has completed its €115 million licensing agreement with Hansa [...]
Remepy has published new peer-reviewed findings showing that its investigational [...]
Basecamp Research has integrated its EDEN antibiotic design and vaccine [...]
Inocras and AimedBio have formed a strategic partnership to integrate [...]
Estonian biotechnology company Icosagen has completed a €45 million expansion [...]
Poolbeg Pharma has secured a South African patent covering the [...]
